US FDA approves Teva Pharmaceuticals' generic obesity drug-February 2024-www.financetom.com

US FDA approves Teva Pharmaceuticals' generic obesity drug

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA approves Teva Pharmaceuticals' generic obesity drug

Aug 28, 2025 6:11 AM

Aug 28 (Reuters) - The U.S. Food and Drug Administration

has approved Teva Pharmaceuticals' cheaper generic

version of Novo Nordisk's older weight-loss drug,

Saxenda, the Israel-based company said on Thursday.

Previous page： Tamil Nadu CM opens Ford's innovation centre in Chennai Next page： Coronavirus: Apple's 42 stores closed until further notice in China

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Tamil Nadu CM opens Ford's innovation centre in Chennai

Feb 6, 2020

Tamil Nadu Chief Minister K Palaniswami on Thursday inaugurated Ford Motors' technology and innovation centre near Chennai.

Coronavirus: Apple's 42 stores closed until further notice in China

Feb 8, 2020

now Apple retail chief Deidre O'Brien revealed that the reopening time is on hold until further notice.

LinkedIn CEO Jeff Weiner to step down after 11 years in the job

Feb 5, 2020

Professional networking platform LinkedIn's chief executive officer, Jeff Weiner, said on Wednesday that he would step down from his position effective June 1.

Wipro wins multi-year global, strategic IT deal from Japanese automotive firm Marelli

Feb 7, 2020

The deal will help Marelli to standardize, simplify and further enhance its IT services at a global level and consolidate several current vendors and workplace end-user services.